Evidence that remdesivir treatment reduces viral titers in patients with COVID-19

Simple item page
dc.contributor.authorBoyd S.
dc.contributor.authorSingh S.
dc.contributor.authorSchilling W.H.K.
dc.contributor.authorWhite N.J.
dc.contributor.correspondenceBoyd S.
dc.contributor.otherMahidol University
dc.date.accessioned2024-12-19T18:31:01Z
dc.date.available2024-12-19T18:31:01Z
dc.date.issued2024-12-05
dc.identifier.citationAntimicrobial agents and chemotherapy Vol.68 No.12 (2024) , e0126624
dc.identifier.doi10.1128/aac.01266-24
dc.identifier.eissn10986596
dc.identifier.pmid39508589
dc.identifier.scopus2-s2.0-85211825798
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/102436
dc.rights.holderSCOPUS
dc.subjectPharmacology, Toxicology and Pharmaceutics
dc.subjectMedicine
dc.titleEvidence that remdesivir treatment reduces viral titers in patients with COVID-19
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85211825798&origin=inward
oaire.citation.issue12
oaire.citation.titleAntimicrobial agents and chemotherapy
oaire.citation.volume68
oairecerif.author.affiliationMahidol Oxford Tropical Medicine Research Unit
oairecerif.author.affiliationNuffield Department of Medicine

Files

Collections

Scopus 2024